Ligase IV inhibitor SCR7 enhances gene editing directed by CRISPR-Cas9 and ssODN in human cancer cells.
about
Ligase IV inhibitor SCR7 enhances gene editing directed by CRISPR-Cas9 and ssODN in human cancer cells.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Ligase IV inhibitor SCR7 enhan ...... d ssODN in human cancer cells.
@en
Ligase IV inhibitor SCR7 enhan ...... d ssODN in human cancer cells.
@nl
type
label
Ligase IV inhibitor SCR7 enhan ...... d ssODN in human cancer cells.
@en
Ligase IV inhibitor SCR7 enhan ...... d ssODN in human cancer cells.
@nl
prefLabel
Ligase IV inhibitor SCR7 enhan ...... d ssODN in human cancer cells.
@en
Ligase IV inhibitor SCR7 enhan ...... d ssODN in human cancer cells.
@nl
P2093
P2860
P1433
P1476
Ligase IV inhibitor SCR7 enhan ...... d ssODN in human cancer cells.
@en
P2093
Dixian Luo
Xiaogang Guo
Yonglong Chen
Yuan-Shan Zhu
Zhaoying Shi
P2860
P2888
P356
10.1186/S13578-018-0200-Z
P577
2018-02-19T00:00:00Z
P6179
1101102469